Related Experiment Videos
Management of COPD: surgical options
1Dipartimento di Medicina Clinica, University La Sapienza, v. le Università 37, I-00185 Rome, Italy. Paolo.Palange@uniroma1.it
Respiration; International Review of Thoracic Diseases
|July 21, 2001
Summary
Lung volume reduction surgery (LVRS) can improve symptoms for severe emphysema patients. However, high surgical mortality and uncertain long-term benefits necessitate further research.
Area of Science:
- Pulmonary Medicine
- Thoracic Surgery
- Respiratory Physiology
Background:
- Chronic obstructive pulmonary disease (COPD) significantly impairs quality of life due to dyspnoea and exercise intolerance.
- End-stage COPD patients often show limited response to conventional treatments and modest gains from physical training.
- Lung transplantation is an option but faces limitations in availability, cost, and patient selection.
Purpose of the Study:
- To review current knowledge on Lung Volume Reduction Surgery (LVRS) for severe emphysema.
- To summarize patient selection criteria, short-term and long-term effects of LVRS.
- To identify future research directions for optimizing LVRS outcomes.
Main Methods:
- Review of existing literature on Lung Volume Reduction Surgery (LVRS).
- Analysis of patient selection criteria for LVRS in emphysema.
- Evaluation of reported short-term and long-term outcomes post-LVRS.
Main Results:
- LVRS can improve lung mechanics, reduce dyspnoea, and enhance exercise tolerance in carefully selected emphysema patients.
- Despite benefits, LVRS is associated with significant surgical mortality and variable patient responses.
- Long-term efficacy data is limited, highlighting the need for further investigation.
Conclusions:
- LVRS offers a potential treatment for severe emphysema, but patient selection is critical.
- Ongoing randomized trials are expected to provide crucial data on the long-term effects of LVRS.
- Further research is needed to refine patient selection and improve outcomes for LVRS.